Pretreatment evaluation of HCV-infected patients is a complex interplay between multiple clinical and viral parameters, leading to a tailored approach that may bring real-life sustained virological response (SVR) rates close to 98%-99%.

Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study

Cento, Valeria;
2017

Abstract

Pretreatment evaluation of HCV-infected patients is a complex interplay between multiple clinical and viral parameters, leading to a tailored approach that may bring real-life sustained virological response (SVR) rates close to 98%-99%.
Administration, Oral
Antiviral Agents
Genotype
Hepacivirus
Hepatitis C, Chronic
Humans
Microbial Sensitivity Tests
Precision Medicine
Proof of Concept Study
RNA, Viral
Sequence Analysis, DNA
Sustained Virologic Response
Treatment Outcome
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11699/65954
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact